← 返回公司对比

Nabla

为医生生成临床记录的AI助手

成立年份2018
国家France
一级垂类Healthcare
二级垂类Ambient Clinical Documentation

AI Native:confirmed。AI直接改造临床文档流程 · 官网

1. 商业数据

收入历史

口径金额期间属性日期状态置信度
Revenue$28mcalendar_yearEst.2025-12-31reported0.6

融资与估值历史

估值类型轮次属性日期状态置信度
$83mfunding_round_unspecified未披露Est.2025-09-18reported0.6
$180mreported_valuation未披露Est.2024-01-05reported0.75

2. 模型与技术路线

未披露

3. 算力与云

未披露

4. 来源与证据

估值估算:funding_round_unspecified reported · 置信度 0.6
Nabla Health Revenue & Valuation (2025) · 2025-09-18 · 原始来源
Nabla Health's most recent disclosed valuation is $83.4M.
收入:revenue reported · 置信度 0.6
Nabla Health Revenue & Valuation (2025) · 2025-09-18 · 原始来源
In 2025, Nabla Health's revenue reached $27.8M. Since its launch in 2018, Nabla Health has shown consistent revenue growth.
估值估算:reported_valuation reported · 置信度 0.75
Nabla raises another $24 million for its AI assistant for doctors that automatically writes clinical notes | TechCrunch · 2024-01-05 · 原始来源
According to a source, Nabla has reached a valuation of $180 million following today’s funding round. The company could also end up raising more money from U.S. investors as part of this round.